| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| C-Reactive Protein | 297 | 2024 | 3851 | 20.900 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 163 | 2024 | 3249 | 14.580 |
Why?
|
| Fluorobenzenes | 50 | 2015 | 179 | 13.440 |
Why?
|
| Cardiovascular Diseases | 308 | 2024 | 15645 | 11.560 |
Why?
|
| Cholesterol, LDL | 126 | 2024 | 2392 | 9.870 |
Why?
|
| Atherosclerosis | 66 | 2024 | 3418 | 8.210 |
Why?
|
| Sulfonamides | 51 | 2015 | 1982 | 7.830 |
Why?
|
| Interleukin-1beta | 29 | 2023 | 1027 | 6.840 |
Why?
|
| Pyrimidines | 50 | 2015 | 3044 | 6.560 |
Why?
|
| Interleukin-6 | 49 | 2024 | 3227 | 5.730 |
Why?
|
| Inflammation | 131 | 2024 | 10869 | 5.710 |
Why?
|
| Myocardial Infarction | 165 | 2024 | 11513 | 5.650 |
Why?
|
| Anti-Inflammatory Agents | 32 | 2023 | 1804 | 5.460 |
Why?
|
| Primary Prevention | 49 | 2024 | 1188 | 4.770 |
Why?
|
| Anticholesteremic Agents | 32 | 2024 | 969 | 4.670 |
Why?
|
| Cholesterol, HDL | 77 | 2023 | 1816 | 4.410 |
Why?
|
| Coronary Disease | 70 | 2024 | 5914 | 3.820 |
Why?
|
| Polymorphism, Single Nucleotide | 193 | 2024 | 16036 | 3.640 |
Why?
|
| Genome-Wide Association Study | 165 | 2024 | 12790 | 3.630 |
Why?
|
| Lipoprotein(a) | 28 | 2024 | 488 | 3.620 |
Why?
|
| Arteriosclerosis | 32 | 2015 | 1055 | 3.420 |
Why?
|
| Polymorphism, Genetic | 53 | 2019 | 4247 | 3.290 |
Why?
|
| Fibrinogen | 38 | 2024 | 892 | 3.260 |
Why?
|
| Randomized Controlled Trials as Topic | 106 | 2024 | 10393 | 3.200 |
Why?
|
| Intercellular Adhesion Molecule-1 | 37 | 2020 | 1132 | 3.110 |
Why?
|
| Hypercholesterolemia | 22 | 2019 | 1144 | 3.100 |
Why?
|
| Coronary Artery Disease | 64 | 2024 | 6573 | 3.060 |
Why?
|
| Colchicine | 7 | 2024 | 256 | 3.050 |
Why?
|
| Thrombosis | 36 | 2022 | 2954 | 2.990 |
Why?
|
| Methotrexate | 20 | 2024 | 1718 | 2.950 |
Why?
|
| Women's Health | 43 | 2024 | 2082 | 2.870 |
Why?
|
| Cholesterol | 57 | 2023 | 2905 | 2.840 |
Why?
|
| Risk Factors | 399 | 2024 | 74886 | 2.790 |
Why?
|
| Double-Blind Method | 117 | 2024 | 12451 | 2.790 |
Why?
|
| Lipids | 54 | 2024 | 3322 | 2.760 |
Why?
|
| Stroke | 92 | 2024 | 9746 | 2.730 |
Why?
|
| Aspirin | 61 | 2021 | 3135 | 2.650 |
Why?
|
| Homocysteine | 28 | 2022 | 637 | 2.550 |
Why?
|
| Humans | 1058 | 2024 | 767040 | 2.540 |
Why?
|
| Antibodies, Monoclonal | 23 | 2024 | 9245 | 2.520 |
Why?
|
| Genetic Loci | 45 | 2022 | 2629 | 2.460 |
Why?
|
| Pravastatin | 21 | 2011 | 393 | 2.380 |
Why?
|
| Genetic Predisposition to Disease | 132 | 2024 | 18063 | 2.360 |
Why?
|
| Middle Aged | 545 | 2024 | 223233 | 2.320 |
Why?
|
| Triglycerides | 49 | 2022 | 2444 | 2.310 |
Why?
|
| Venous Thrombosis | 24 | 2023 | 1321 | 2.270 |
Why?
|
| Lipoproteins | 22 | 2022 | 871 | 2.220 |
Why?
|
| Risk Assessment | 118 | 2024 | 24299 | 2.160 |
Why?
|
| Dyslipidemias | 16 | 2024 | 872 | 2.090 |
Why?
|
| Inflammation Mediators | 27 | 2019 | 1889 | 2.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 63 | 2023 | 12250 | 2.030 |
Why?
|
| Blood Pressure | 59 | 2024 | 8531 | 1.970 |
Why?
|
| Hyperlipidemias | 24 | 2023 | 771 | 1.940 |
Why?
|
| Female | 604 | 2024 | 396660 | 1.930 |
Why?
|
| Aged | 366 | 2024 | 171319 | 1.860 |
Why?
|
| Genetic Variation | 56 | 2020 | 6611 | 1.840 |
Why?
|
| Prospective Studies | 224 | 2024 | 54886 | 1.830 |
Why?
|
| Factor V | 18 | 2009 | 168 | 1.770 |
Why?
|
| Risk | 83 | 2020 | 9606 | 1.750 |
Why?
|
| Thromboembolism | 16 | 2007 | 1003 | 1.730 |
Why?
|
| Apolipoprotein A-I | 18 | 2024 | 305 | 1.720 |
Why?
|
| Interleukin-18 | 5 | 2020 | 251 | 1.720 |
Why?
|
| Incidence | 110 | 2024 | 21526 | 1.700 |
Why?
|
| Lipoproteins, LDL | 16 | 2020 | 640 | 1.660 |
Why?
|
| Renal Insufficiency, Chronic | 12 | 2022 | 2299 | 1.640 |
Why?
|
| Male | 461 | 2024 | 364203 | 1.570 |
Why?
|
| Lipoproteins, HDL | 17 | 2024 | 679 | 1.570 |
Why?
|
| Hypolipidemic Agents | 13 | 2024 | 609 | 1.490 |
Why?
|
| Genotype | 103 | 2022 | 13035 | 1.490 |
Why?
|
| Venous Thromboembolism | 20 | 2022 | 1883 | 1.460 |
Why?
|
| Gene Frequency | 48 | 2024 | 3621 | 1.460 |
Why?
|
| Peripheral Vascular Diseases | 20 | 2020 | 488 | 1.440 |
Why?
|
| Proportional Hazards Models | 75 | 2024 | 12536 | 1.430 |
Why?
|
| Case-Control Studies | 123 | 2024 | 22254 | 1.390 |
Why?
|
| Warfarin | 16 | 2022 | 1493 | 1.380 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 8 | 2022 | 127 | 1.350 |
Why?
|
| Hypertension | 55 | 2024 | 8615 | 1.340 |
Why?
|
| Secondary Prevention | 20 | 2024 | 1472 | 1.330 |
Why?
|
| Brain Ischemia | 22 | 2022 | 3001 | 1.330 |
Why?
|
| Psoriasis | 8 | 2020 | 925 | 1.280 |
Why?
|
| Hypertriglyceridemia | 8 | 2022 | 293 | 1.260 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 18 | 2021 | 425 | 1.230 |
Why?
|
| Follow-Up Studies | 104 | 2024 | 39317 | 1.210 |
Why?
|
| Practice Guidelines as Topic | 15 | 2018 | 7435 | 1.170 |
Why?
|
| Benzoxazoles | 4 | 2024 | 92 | 1.160 |
Why?
|
| Myocardial Ischemia | 14 | 2021 | 2131 | 1.130 |
Why?
|
| Mendelian Randomization Analysis | 18 | 2022 | 1040 | 1.120 |
Why?
|
| Genome, Human | 32 | 2022 | 4441 | 1.120 |
Why?
|
| Anticoagulants | 20 | 2023 | 4854 | 1.100 |
Why?
|
| Cohort Studies | 132 | 2024 | 41718 | 1.070 |
Why?
|
| Body Mass Index | 77 | 2021 | 13048 | 1.040 |
Why?
|
| Fasting | 11 | 2020 | 1607 | 1.030 |
Why?
|
| Predictive Value of Tests | 74 | 2020 | 15424 | 1.030 |
Why?
|
| Smoking | 55 | 2021 | 9081 | 1.030 |
Why?
|
| Quantitative Trait Loci | 27 | 2022 | 2131 | 1.020 |
Why?
|
| Hyperlipoproteinemia Type II | 6 | 2018 | 396 | 1.010 |
Why?
|
| Butyrates | 4 | 2024 | 164 | 1.010 |
Why?
|
| Tissue Plasminogen Activator | 18 | 2021 | 1164 | 1.000 |
Why?
|
| Estrogen Replacement Therapy | 15 | 2011 | 1209 | 1.000 |
Why?
|
| Fibrinolytic Agents | 7 | 2022 | 2079 | 0.980 |
Why?
|
| Vasculitis | 9 | 2024 | 526 | 0.910 |
Why?
|
| Nonprescription Drugs | 2 | 2024 | 119 | 0.910 |
Why?
|
| Familial Mediterranean Fever | 1 | 2024 | 66 | 0.890 |
Why?
|
| Menarche | 9 | 2024 | 538 | 0.870 |
Why?
|
| Vitamin E | 14 | 2018 | 872 | 0.850 |
Why?
|
| Alleles | 44 | 2022 | 6893 | 0.850 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 10 | 2011 | 692 | 0.840 |
Why?
|
| Serine Proteinase Inhibitors | 4 | 2019 | 174 | 0.830 |
Why?
|
| Apolipoproteins B | 12 | 2023 | 385 | 0.820 |
Why?
|
| Thrombophlebitis | 9 | 1998 | 289 | 0.820 |
Why?
|
| Platelet Aggregation Inhibitors | 21 | 2021 | 2764 | 0.820 |
Why?
|
| Plaque, Atherosclerotic | 5 | 2023 | 1549 | 0.800 |
Why?
|
| Treatment Outcome | 80 | 2024 | 65295 | 0.800 |
Why?
|
| Antirheumatic Agents | 8 | 2024 | 1379 | 0.800 |
Why?
|
| Obesity | 49 | 2022 | 13085 | 0.780 |
Why?
|
| Apolipoproteins | 13 | 2022 | 328 | 0.770 |
Why?
|
| Blood Glucose | 15 | 2021 | 6421 | 0.760 |
Why?
|
| Adult | 220 | 2024 | 223317 | 0.760 |
Why?
|
| Cerebrovascular Disorders | 13 | 2023 | 1478 | 0.750 |
Why?
|
| Gout | 5 | 2023 | 620 | 0.740 |
Why?
|
| Self Medication | 1 | 2021 | 115 | 0.730 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 3 | 2014 | 64 | 0.710 |
Why?
|
| Neutrophils | 4 | 2023 | 3779 | 0.710 |
Why?
|
| Aged, 80 and over | 103 | 2024 | 59548 | 0.700 |
Why?
|
| Injections, Subcutaneous | 5 | 2021 | 685 | 0.700 |
Why?
|
| Lymphocytes | 5 | 2023 | 2605 | 0.690 |
Why?
|
| Chromosomes, Human, Pair 9 | 5 | 2009 | 534 | 0.680 |
Why?
|
| Postmenopause | 18 | 2018 | 2518 | 0.680 |
Why?
|
| Lipid Metabolism | 11 | 2021 | 1895 | 0.670 |
Why?
|
| Acute Coronary Syndrome | 5 | 2022 | 2193 | 0.670 |
Why?
|
| Haplotypes | 23 | 2022 | 2722 | 0.660 |
Why?
|
| Heptanoic Acids | 7 | 2010 | 344 | 0.660 |
Why?
|
| Simvastatin | 6 | 2016 | 345 | 0.650 |
Why?
|
| United States | 96 | 2024 | 72971 | 0.650 |
Why?
|
| Interleukin-1 | 4 | 2018 | 1252 | 0.650 |
Why?
|
| Meta-Analysis as Topic | 14 | 2021 | 1364 | 0.650 |
Why?
|
| Periodontal Diseases | 3 | 2023 | 454 | 0.650 |
Why?
|
| Anemia | 3 | 2023 | 1514 | 0.650 |
Why?
|
| Dose-Response Relationship, Drug | 24 | 2022 | 10748 | 0.640 |
Why?
|
| Body Height | 12 | 2022 | 1565 | 0.640 |
Why?
|
| Alcohol Drinking | 23 | 2020 | 4045 | 0.630 |
Why?
|
| Cholesterol Ester Transfer Proteins | 5 | 2016 | 113 | 0.620 |
Why?
|
| Prothrombin | 8 | 2014 | 194 | 0.600 |
Why?
|
| Insulin Resistance | 16 | 2021 | 3986 | 0.600 |
Why?
|
| Receptors, Adrenergic, beta-2 | 4 | 2009 | 216 | 0.600 |
Why?
|
| Metabolic Networks and Pathways | 5 | 2018 | 800 | 0.600 |
Why?
|
| Arthritis, Rheumatoid | 8 | 2024 | 3778 | 0.590 |
Why?
|
| Decision Support Techniques | 7 | 2024 | 2006 | 0.590 |
Why?
|
| Pulmonary Embolism | 14 | 2022 | 2598 | 0.590 |
Why?
|
| Cardiology | 6 | 2019 | 1701 | 0.580 |
Why?
|
| Vascular Diseases | 6 | 2020 | 1161 | 0.580 |
Why?
|
| Odds Ratio | 30 | 2019 | 9660 | 0.570 |
Why?
|
| Clinical Trials as Topic | 23 | 2024 | 8048 | 0.570 |
Why?
|
| Mortality | 10 | 2024 | 2909 | 0.560 |
Why?
|
| Hydrochlorothiazide | 4 | 2016 | 95 | 0.560 |
Why?
|
| Valine | 3 | 2008 | 410 | 0.560 |
Why?
|
| Placebos | 15 | 2020 | 1660 | 0.560 |
Why?
|
| Women | 1 | 2019 | 225 | 0.560 |
Why?
|
| Drug Therapy, Combination | 13 | 2024 | 6310 | 0.560 |
Why?
|
| Genetic Association Studies | 13 | 2019 | 2744 | 0.550 |
Why?
|
| Fibrinolysis | 8 | 2015 | 331 | 0.550 |
Why?
|
| Folic Acid | 6 | 2021 | 1336 | 0.550 |
Why?
|
| Diabetes Mellitus | 24 | 2022 | 5886 | 0.550 |
Why?
|
| Telomere | 4 | 2011 | 943 | 0.550 |
Why?
|
| Adiposity | 13 | 2020 | 1894 | 0.550 |
Why?
|
| Data Interpretation, Statistical | 10 | 2018 | 2698 | 0.540 |
Why?
|
| Phospholipases A2 | 4 | 2012 | 197 | 0.540 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 10 | 2016 | 2270 | 0.530 |
Why?
|
| Dietary Carbohydrates | 4 | 2014 | 896 | 0.530 |
Why?
|
| Exercise | 18 | 2022 | 5954 | 0.530 |
Why?
|
| Acute-Phase Reaction | 2 | 2014 | 91 | 0.530 |
Why?
|
| Age Factors | 42 | 2021 | 18401 | 0.530 |
Why?
|
| Lovastatin | 5 | 2003 | 114 | 0.530 |
Why?
|
| Uric Acid | 3 | 2018 | 805 | 0.520 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 9 | 2021 | 279 | 0.520 |
Why?
|
| Osteoarthritis, Hip | 1 | 2020 | 409 | 0.520 |
Why?
|
| Eicosapentaenoic Acid | 5 | 2022 | 565 | 0.520 |
Why?
|
| Salicylates | 1 | 2016 | 127 | 0.510 |
Why?
|
| Europe | 19 | 2024 | 3432 | 0.510 |
Why?
|
| Magnetic Resonance Spectroscopy | 8 | 2024 | 3684 | 0.510 |
Why?
|
| Muscular Diseases | 4 | 2013 | 552 | 0.510 |
Why?
|
| Migraine Disorders | 11 | 2022 | 1712 | 0.500 |
Why?
|
| Tetrazoles | 4 | 2016 | 923 | 0.500 |
Why?
|
| Arthritis, Psoriatic | 1 | 2018 | 219 | 0.500 |
Why?
|
| Catechol O-Methyltransferase | 4 | 2019 | 251 | 0.500 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2018 | 283 | 0.500 |
Why?
|
| Multivariate Analysis | 32 | 2019 | 12069 | 0.500 |
Why?
|
| Arteries | 4 | 2015 | 1123 | 0.500 |
Why?
|
| Glomerular Filtration Rate | 13 | 2022 | 2227 | 0.490 |
Why?
|
| Pyrroles | 7 | 2010 | 1122 | 0.490 |
Why?
|
| Risk Reduction Behavior | 9 | 2018 | 1119 | 0.490 |
Why?
|
| Phospholipases A | 3 | 2006 | 204 | 0.480 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 5 | 2022 | 246 | 0.480 |
Why?
|
| Angina, Unstable | 6 | 2015 | 893 | 0.480 |
Why?
|
| Cell Adhesion Molecules | 11 | 2017 | 1612 | 0.470 |
Why?
|
| Financing, Organized | 2 | 2006 | 202 | 0.470 |
Why?
|
| Natriuretic Peptide, Brain | 7 | 2017 | 1749 | 0.470 |
Why?
|
| P-Selectin | 5 | 2011 | 598 | 0.470 |
Why?
|
| Algorithms | 15 | 2019 | 14098 | 0.470 |
Why?
|
| Research Support as Topic | 3 | 2008 | 697 | 0.470 |
Why?
|
| Dietary Fats | 6 | 2019 | 2001 | 0.470 |
Why?
|
| Atrial Fibrillation | 13 | 2022 | 5180 | 0.460 |
Why?
|
| Fish Oils | 3 | 2022 | 483 | 0.460 |
Why?
|
| Hemoglobins | 5 | 2023 | 1531 | 0.460 |
Why?
|
| Heart Diseases | 9 | 2019 | 2817 | 0.460 |
Why?
|
| Proteins | 15 | 2019 | 6001 | 0.460 |
Why?
|
| Rheumatoid Factor | 1 | 2014 | 185 | 0.450 |
Why?
|
| Phenotype | 44 | 2022 | 16718 | 0.450 |
Why?
|
| Cytokines | 10 | 2023 | 7446 | 0.450 |
Why?
|
| Regression Analysis | 15 | 2023 | 6331 | 0.440 |
Why?
|
| Antihypertensive Agents | 10 | 2016 | 2030 | 0.440 |
Why?
|
| Amino Acid Substitution | 6 | 2014 | 1743 | 0.440 |
Why?
|
| Insulin | 11 | 2019 | 6602 | 0.440 |
Why?
|
| Fatty Acids, Omega-3 | 4 | 2018 | 1399 | 0.440 |
Why?
|
| Dietary Proteins | 3 | 2014 | 960 | 0.440 |
Why?
|
| Physician's Role | 1 | 2020 | 923 | 0.440 |
Why?
|
| Hemostasis | 7 | 2021 | 467 | 0.440 |
Why?
|
| Thrombophilia | 6 | 2010 | 308 | 0.440 |
Why?
|
| Troponin T | 5 | 2017 | 786 | 0.440 |
Why?
|
| Microvascular Angina | 1 | 2013 | 14 | 0.430 |
Why?
|
| Diabetes Complications | 9 | 2020 | 1319 | 0.430 |
Why?
|
| Receptors, Interleukin-6 | 3 | 2022 | 224 | 0.430 |
Why?
|
| Prognosis | 44 | 2024 | 29963 | 0.430 |
Why?
|
| Alanine Transaminase | 1 | 2016 | 609 | 0.430 |
Why?
|
| Migraine without Aura | 3 | 2021 | 82 | 0.430 |
Why?
|
| Proteomics | 6 | 2023 | 3913 | 0.420 |
Why?
|
| Hematuria | 1 | 2014 | 232 | 0.420 |
Why?
|
| Evidence-Based Medicine | 7 | 2017 | 3700 | 0.420 |
Why?
|
| Recurrence | 23 | 2024 | 8504 | 0.420 |
Why?
|
| Peripheral Arterial Disease | 9 | 2024 | 1304 | 0.420 |
Why?
|
| Chromosome Mapping | 11 | 2022 | 4616 | 0.420 |
Why?
|
| Time Factors | 48 | 2024 | 40154 | 0.410 |
Why?
|
| Multifactorial Inheritance | 13 | 2024 | 1422 | 0.410 |
Why?
|
| Papillomaviridae | 1 | 2019 | 1139 | 0.410 |
Why?
|
| Drug Administration Schedule | 15 | 2020 | 4855 | 0.400 |
Why?
|
| Organic Anion Transporters | 1 | 2013 | 101 | 0.400 |
Why?
|
| Inflammasomes | 4 | 2022 | 540 | 0.400 |
Why?
|
| beta Carotene | 18 | 2019 | 523 | 0.400 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2014 | 239 | 0.400 |
Why?
|
| Statistics, Nonparametric | 9 | 2018 | 2850 | 0.400 |
Why?
|
| Lectins | 1 | 2014 | 490 | 0.400 |
Why?
|
| Helicobacter pylori | 3 | 2001 | 380 | 0.390 |
Why?
|
| Adipokines | 1 | 2014 | 309 | 0.390 |
Why?
|
| Coronary Restenosis | 3 | 2010 | 396 | 0.390 |
Why?
|
| Antibodies | 2 | 2017 | 2419 | 0.390 |
Why?
|
| Quantitative Trait, Heritable | 4 | 2021 | 539 | 0.390 |
Why?
|
| Coronary Thrombosis | 4 | 2002 | 440 | 0.390 |
Why?
|
| Endotoxins | 1 | 2014 | 519 | 0.390 |
Why?
|
| Immunosuppressive Agents | 3 | 2020 | 4210 | 0.390 |
Why?
|
| Waist-Hip Ratio | 12 | 2019 | 520 | 0.390 |
Why?
|
| Factor VII | 5 | 2021 | 139 | 0.390 |
Why?
|
| Body Size | 5 | 2019 | 462 | 0.380 |
Why?
|
| Internet | 1 | 2024 | 3114 | 0.380 |
Why?
|
| Life Expectancy | 3 | 2024 | 1248 | 0.380 |
Why?
|
| Menopause | 10 | 2023 | 1655 | 0.380 |
Why?
|
| Mass Screening | 9 | 2017 | 5456 | 0.380 |
Why?
|
| Signal Transduction | 14 | 2021 | 23621 | 0.380 |
Why?
|
| Macular Degeneration | 5 | 2017 | 1015 | 0.380 |
Why?
|
| Mixed Function Oxygenases | 5 | 2011 | 265 | 0.380 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2014 | 462 | 0.380 |
Why?
|
| Patient Admission | 1 | 2019 | 1364 | 0.380 |
Why?
|
| Oligonucleotides | 1 | 2014 | 561 | 0.370 |
Why?
|
| Arterial Occlusive Diseases | 7 | 2008 | 743 | 0.370 |
Why?
|
| Endometriosis | 4 | 2023 | 873 | 0.370 |
Why?
|
| Tumor Necrosis Factor-alpha | 9 | 2022 | 4349 | 0.370 |
Why?
|
| Cause of Death | 12 | 2024 | 3717 | 0.360 |
Why?
|
| Membrane Proteins | 15 | 2019 | 7868 | 0.360 |
Why?
|
| CD40 Ligand | 4 | 2019 | 528 | 0.360 |
Why?
|
| Apolipoproteins A | 2 | 2008 | 95 | 0.360 |
Why?
|
| Hormone Replacement Therapy | 9 | 2009 | 756 | 0.360 |
Why?
|
| Life Style | 12 | 2020 | 3931 | 0.350 |
Why?
|
| Dioxygenases | 2 | 2023 | 353 | 0.350 |
Why?
|
| Coronary Angiography | 7 | 2017 | 4525 | 0.350 |
Why?
|
| ABO Blood-Group System | 3 | 2011 | 381 | 0.350 |
Why?
|
| Diet | 14 | 2023 | 8089 | 0.350 |
Why?
|
| Heart Failure | 8 | 2023 | 11877 | 0.350 |
Why?
|
| Polysaccharides | 5 | 2024 | 1020 | 0.350 |
Why?
|
| Apolipoproteins E | 7 | 2020 | 1459 | 0.350 |
Why?
|
| Cross-Sectional Studies | 39 | 2023 | 26325 | 0.350 |
Why?
|
| Kidney | 11 | 2024 | 7063 | 0.350 |
Why?
|
| Drug and Narcotic Control | 1 | 2011 | 145 | 0.350 |
Why?
|
| Adiponectin | 5 | 2019 | 1115 | 0.350 |
Why?
|
| Diet, Mediterranean | 3 | 2024 | 746 | 0.350 |
Why?
|
| Migraine with Aura | 3 | 2022 | 203 | 0.350 |
Why?
|
| Immunoglobulin M | 2 | 2014 | 1527 | 0.340 |
Why?
|
| Autoimmune Diseases | 1 | 2022 | 2255 | 0.340 |
Why?
|
| Thyroid Gland | 3 | 2024 | 1170 | 0.340 |
Why?
|
| Outpatients | 3 | 2022 | 1600 | 0.340 |
Why?
|
| Logistic Models | 23 | 2017 | 13284 | 0.340 |
Why?
|
| Periodontitis | 5 | 2019 | 576 | 0.340 |
Why?
|
| Disease Management | 2 | 2018 | 2531 | 0.340 |
Why?
|
| Lipoprotein Lipase | 2 | 2011 | 133 | 0.340 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2009 | 276 | 0.340 |
Why?
|
| Multicenter Studies as Topic | 7 | 2020 | 1733 | 0.340 |
Why?
|
| Kidney Diseases | 6 | 2020 | 2099 | 0.340 |
Why?
|
| Osteoarthritis, Knee | 1 | 2020 | 1251 | 0.340 |
Why?
|
| Adipose Tissue | 9 | 2019 | 3324 | 0.340 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 3 | 2024 | 325 | 0.340 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2020 | 1417 | 0.330 |
Why?
|
| Models, Genetic | 10 | 2019 | 3445 | 0.330 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2008 | 138 | 0.330 |
Why?
|
| PPAR alpha | 2 | 2022 | 177 | 0.330 |
Why?
|
| Genetic Markers | 11 | 2016 | 2602 | 0.330 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2020 | 1389 | 0.330 |
Why?
|
| Peer Review, Research | 1 | 2013 | 343 | 0.330 |
Why?
|
| Diet, Reducing | 1 | 2013 | 487 | 0.330 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2009 | 17 | 0.330 |
Why?
|
| Chlamydophila pneumoniae | 2 | 1999 | 53 | 0.330 |
Why?
|
| Lipoproteins, VLDL | 5 | 2020 | 198 | 0.330 |
Why?
|
| Fertility | 4 | 2023 | 771 | 0.330 |
Why?
|
| Methylmalonyl-CoA Mutase | 1 | 2009 | 23 | 0.320 |
Why?
|
| Dipeptidases | 1 | 2009 | 38 | 0.320 |
Why?
|
| Models, Statistical | 11 | 2016 | 5098 | 0.320 |
Why?
|
| European Union | 1 | 2010 | 158 | 0.320 |
Why?
|
| Patient Selection | 7 | 2020 | 4256 | 0.320 |
Why?
|
| Immunity, Innate | 7 | 2022 | 3076 | 0.320 |
Why?
|
| Arteritis | 2 | 2022 | 160 | 0.320 |
Why?
|
| Puberty | 3 | 2024 | 501 | 0.320 |
Why?
|
| Amino Acids, Branched-Chain | 3 | 2021 | 267 | 0.320 |
Why?
|
| Motor Activity | 8 | 2014 | 2713 | 0.320 |
Why?
|
| Pyrrolizidine Alkaloids | 4 | 1990 | 10 | 0.320 |
Why?
|
| Sex Factors | 21 | 2021 | 10622 | 0.320 |
Why?
|
| Drug Labeling | 1 | 2011 | 251 | 0.320 |
Why?
|
| Particle Size | 6 | 2023 | 1633 | 0.310 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 4 | 2018 | 502 | 0.310 |
Why?
|
| Microvessels | 1 | 2013 | 585 | 0.310 |
Why?
|
| Cardiovascular Agents | 3 | 2016 | 849 | 0.310 |
Why?
|
| Hospitals, Proprietary | 1 | 2008 | 38 | 0.310 |
Why?
|
| Epistasis, Genetic | 5 | 2020 | 353 | 0.310 |
Why?
|
| Peptide Fragments | 6 | 2017 | 5141 | 0.310 |
Why?
|
| Hospitals, Voluntary | 1 | 2008 | 39 | 0.310 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2008 | 299 | 0.310 |
Why?
|
| Chemistry, Clinical | 1 | 2008 | 64 | 0.310 |
Why?
|
| Hexokinase | 1 | 2008 | 124 | 0.300 |
Why?
|
| Calcinosis | 2 | 2011 | 1481 | 0.300 |
Why?
|
| Confidence Intervals | 10 | 2018 | 2920 | 0.300 |
Why?
|
| von Willebrand Factor | 5 | 2021 | 680 | 0.300 |
Why?
|
| Fractures, Bone | 3 | 2015 | 2062 | 0.300 |
Why?
|
| Socioeconomic Factors | 8 | 2024 | 7848 | 0.300 |
Why?
|
| Immunoassay | 5 | 2015 | 744 | 0.300 |
Why?
|
| Point Mutation | 6 | 2002 | 1591 | 0.290 |
Why?
|
| Antioxidants | 14 | 2015 | 1671 | 0.290 |
Why?
|
| Interleukin-1alpha | 1 | 2008 | 88 | 0.290 |
Why?
|
| Leukocytes | 3 | 2019 | 2034 | 0.290 |
Why?
|
| Brachial Artery | 7 | 2018 | 373 | 0.290 |
Why?
|
| Serum Amyloid A Protein | 14 | 2009 | 128 | 0.290 |
Why?
|
| Angioplasty | 1 | 2010 | 355 | 0.290 |
Why?
|
| Anthropometry | 4 | 2016 | 1345 | 0.290 |
Why?
|
| Proprotein Convertases | 3 | 2018 | 95 | 0.290 |
Why?
|
| Reproducibility of Results | 18 | 2018 | 20169 | 0.290 |
Why?
|
| Thrombolytic Therapy | 9 | 1996 | 2054 | 0.280 |
Why?
|
| Hemorrhage | 9 | 2022 | 3464 | 0.280 |
Why?
|
| Death, Sudden, Cardiac | 8 | 2013 | 1567 | 0.280 |
Why?
|
| Sex Characteristics | 8 | 2022 | 2647 | 0.280 |
Why?
|
| Reference Values | 16 | 2017 | 4918 | 0.280 |
Why?
|
| Immune System | 1 | 2012 | 799 | 0.280 |
Why?
|
| Longevity | 3 | 2021 | 1083 | 0.280 |
Why?
|
| Homozygote | 7 | 2019 | 1774 | 0.280 |
Why?
|
| Metformin | 2 | 2017 | 908 | 0.280 |
Why?
|
| Papillomavirus Infections | 1 | 2019 | 1639 | 0.270 |
Why?
|
| Reproduction | 3 | 2023 | 646 | 0.270 |
Why?
|
| Aging | 11 | 2023 | 8729 | 0.270 |
Why?
|
| Solubility | 7 | 2008 | 1078 | 0.270 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2006 | 50 | 0.270 |
Why?
|
| Endpoint Determination | 4 | 2013 | 592 | 0.270 |
Why?
|
| Immunoglobulin G | 7 | 2024 | 4560 | 0.270 |
Why?
|
| Intracranial Thrombosis | 1 | 2007 | 109 | 0.270 |
Why?
|
| Heterozygote | 7 | 2014 | 2794 | 0.260 |
Why?
|
| Carboxypeptidase B | 1 | 2005 | 6 | 0.260 |
Why?
|
| Receptors, Immunologic | 2 | 2017 | 1418 | 0.260 |
Why?
|
| Complement Factor H | 2 | 2006 | 110 | 0.260 |
Why?
|
| Helicobacter Infections | 2 | 2001 | 390 | 0.260 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2007 | 152 | 0.260 |
Why?
|
| Carrier Proteins | 5 | 2020 | 4925 | 0.260 |
Why?
|
| Disease Susceptibility | 5 | 2009 | 1791 | 0.260 |
Why?
|
| Sensitivity and Specificity | 18 | 2011 | 14672 | 0.260 |
Why?
|
| Docosahexaenoic Acids | 4 | 2020 | 914 | 0.260 |
Why?
|
| Linkage Disequilibrium | 10 | 2022 | 1996 | 0.260 |
Why?
|
| Hydroxychloroquine | 2 | 2024 | 427 | 0.260 |
Why?
|
| Comorbidity | 21 | 2023 | 10582 | 0.260 |
Why?
|
| Liver Diseases | 1 | 2014 | 1304 | 0.260 |
Why?
|
| Pharmacogenetics | 7 | 2022 | 682 | 0.250 |
Why?
|
| DNA | 5 | 2017 | 7210 | 0.250 |
Why?
|
| Organizations, Nonprofit | 1 | 2006 | 105 | 0.250 |
Why?
|
| Pneumonia | 2 | 2020 | 2159 | 0.250 |
Why?
|
| Publishing | 1 | 2013 | 837 | 0.250 |
Why?
|
| Simplexvirus | 2 | 1999 | 805 | 0.250 |
Why?
|
| Tryptophan-tRNA Ligase | 1 | 2005 | 16 | 0.250 |
Why?
|
| Mutation | 14 | 2020 | 30211 | 0.240 |
Why?
|
| Disease-Free Survival | 8 | 2016 | 6844 | 0.240 |
Why?
|
| Acute-Phase Proteins | 6 | 2016 | 251 | 0.240 |
Why?
|
| Gangrene | 2 | 2024 | 92 | 0.240 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 1999 | 577 | 0.240 |
Why?
|
| Waist Circumference | 8 | 2017 | 935 | 0.240 |
Why?
|
| Vitamin D | 4 | 2018 | 3312 | 0.240 |
Why?
|
| Beverages | 5 | 2012 | 819 | 0.240 |
Why?
|
| Postprandial Period | 4 | 2015 | 320 | 0.240 |
Why?
|
| Glycoproteins | 7 | 2017 | 2200 | 0.240 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2014 | 1107 | 0.240 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 10 | 2012 | 3804 | 0.240 |
Why?
|
| E-Selectin | 4 | 2014 | 576 | 0.240 |
Why?
|
| Cyclooxygenase Inhibitors | 6 | 2014 | 361 | 0.240 |
Why?
|
| Acetylglucosamine | 2 | 2016 | 188 | 0.240 |
Why?
|
| Creatine Kinase | 4 | 2017 | 683 | 0.240 |
Why?
|
| Vitamin B Complex | 1 | 2007 | 299 | 0.240 |
Why?
|
| Cytomegalovirus | 2 | 1999 | 751 | 0.230 |
Why?
|
| Vitamins | 5 | 2018 | 1639 | 0.230 |
Why?
|
| Hyperhomocysteinemia | 3 | 2021 | 117 | 0.230 |
Why?
|
| International Normalized Ratio | 6 | 2021 | 382 | 0.230 |
Why?
|
| Hepatic Veno-Occlusive Disease | 4 | 1990 | 220 | 0.230 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 2212 | 0.230 |
Why?
|
| Creatinine | 6 | 2022 | 1916 | 0.230 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 2 | 2008 | 428 | 0.230 |
Why?
|
| Chemokines, CC | 2 | 2005 | 286 | 0.230 |
Why?
|
| Kaplan-Meier Estimate | 10 | 2024 | 6513 | 0.230 |
Why?
|
| Cystatins | 2 | 2001 | 55 | 0.220 |
Why?
|
| Health Surveys | 2 | 2019 | 4056 | 0.220 |
Why?
|
| Linear Models | 15 | 2018 | 5875 | 0.220 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 792 | 0.220 |
Why?
|
| Oxidative Stress | 3 | 2012 | 3139 | 0.220 |
Why?
|
| Single-Blind Method | 5 | 2022 | 1587 | 0.220 |
Why?
|
| Prevalence | 17 | 2018 | 15851 | 0.220 |
Why?
|
| alpha-Tocopherol | 2 | 2019 | 127 | 0.220 |
Why?
|
| Nephelometry and Turbidimetry | 5 | 2007 | 91 | 0.220 |
Why?
|
| Animals | 32 | 2024 | 168965 | 0.220 |
Why?
|
| Endothelium, Vascular | 7 | 2020 | 4424 | 0.220 |
Why?
|
| Survival Rate | 14 | 2018 | 12823 | 0.210 |
Why?
|
| Immunity, Cellular | 2 | 2021 | 1560 | 0.210 |
Why?
|
| Myocardial Revascularization | 4 | 2013 | 795 | 0.210 |
Why?
|
| Renal Dialysis | 2 | 2024 | 1790 | 0.210 |
Why?
|
| Canada | 3 | 2016 | 2127 | 0.210 |
Why?
|
| Drug Approval | 1 | 2010 | 820 | 0.210 |
Why?
|
| Private Sector | 1 | 2006 | 397 | 0.210 |
Why?
|
| Proinsulin | 1 | 2003 | 134 | 0.210 |
Why?
|
| ROC Curve | 3 | 2015 | 3618 | 0.210 |
Why?
|
| Mineral Oil | 1 | 2022 | 21 | 0.210 |
Why?
|
| Calcium, Dietary | 1 | 2005 | 533 | 0.210 |
Why?
|
| Phytosterols | 1 | 2022 | 55 | 0.210 |
Why?
|
| Thyroxine | 2 | 2024 | 666 | 0.200 |
Why?
|
| Public Health | 2 | 2019 | 2681 | 0.200 |
Why?
|
| Models, Cardiovascular | 3 | 2020 | 978 | 0.200 |
Why?
|
| Hormones | 1 | 2006 | 865 | 0.200 |
Why?
|
| Angioplasty, Balloon, Coronary | 4 | 2011 | 1721 | 0.200 |
Why?
|
| Energy Intake | 5 | 2018 | 2145 | 0.200 |
Why?
|
| Genomics | 12 | 2022 | 5924 | 0.200 |
Why?
|
| Age Distribution | 6 | 2016 | 2870 | 0.200 |
Why?
|
| DNA Virus Infections | 1 | 2002 | 15 | 0.200 |
Why?
|
| Neutropenia | 2 | 2017 | 892 | 0.200 |
Why?
|
| Acyl Coenzyme A | 1 | 2002 | 56 | 0.200 |
Why?
|
| Genetic Techniques | 1 | 2005 | 427 | 0.190 |
Why?
|
| Neoplasms | 14 | 2019 | 22350 | 0.190 |
Why?
|
| Apolipoprotein B-100 | 4 | 2020 | 157 | 0.190 |
Why?
|
| Software Validation | 1 | 2021 | 59 | 0.190 |
Why?
|
| Polyglutamic Acid | 1 | 2021 | 46 | 0.190 |
Why?
|
| Infusions, Intravenous | 6 | 2024 | 2227 | 0.190 |
Why?
|
| Leiomyoma | 2 | 2019 | 644 | 0.190 |
Why?
|
| Birth Weight | 2 | 2020 | 2122 | 0.190 |
Why?
|
| Hypoglycemic Agents | 4 | 2017 | 3108 | 0.190 |
Why?
|
| Platelet Aggregation | 3 | 2009 | 769 | 0.190 |
Why?
|
| Genetic Pleiotropy | 3 | 2022 | 181 | 0.190 |
Why?
|
| Genetics, Population | 6 | 2018 | 943 | 0.190 |
Why?
|
| Leptin | 3 | 2020 | 1599 | 0.190 |
Why?
|
| Angina Pectoris | 5 | 2004 | 956 | 0.190 |
Why?
|
| Corn Oil | 1 | 2020 | 29 | 0.180 |
Why?
|
| Body Weight | 6 | 2014 | 4627 | 0.180 |
Why?
|
| Health | 3 | 2011 | 398 | 0.180 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 3 | 2013 | 347 | 0.180 |
Why?
|
| Renin-Angiotensin System | 3 | 2008 | 736 | 0.180 |
Why?
|
| Fibroblast Growth Factors | 3 | 2018 | 873 | 0.180 |
Why?
|
| Uromodulin | 3 | 2019 | 48 | 0.180 |
Why?
|
| Causality | 5 | 2023 | 1253 | 0.180 |
Why?
|
| Fatty Acids | 5 | 2016 | 1806 | 0.180 |
Why?
|
| Severity of Illness Index | 14 | 2014 | 15925 | 0.180 |
Why?
|
| Molecular Weight | 3 | 2012 | 2168 | 0.180 |
Why?
|
| Adolescent | 38 | 2024 | 89046 | 0.180 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2021 | 326 | 0.180 |
Why?
|
| Sialoglycoproteins | 1 | 2001 | 316 | 0.180 |
Why?
|
| Cyclooxygenase 2 | 4 | 2014 | 597 | 0.180 |
Why?
|
| Bayes Theorem | 6 | 2016 | 2353 | 0.180 |
Why?
|
| Body Fat Distribution | 3 | 2019 | 246 | 0.180 |
Why?
|
| Drug Interactions | 2 | 2024 | 1419 | 0.170 |
Why?
|
| Coronary Vessels | 1 | 2012 | 3114 | 0.170 |
Why?
|
| Systole | 7 | 2018 | 935 | 0.170 |
Why?
|
| Forecasting | 5 | 2017 | 2936 | 0.170 |
Why?
|
| Drug Dosage Calculations | 2 | 2011 | 116 | 0.170 |
Why?
|
| Lymphocyte Count | 2 | 2021 | 793 | 0.170 |
Why?
|
| Diabetic Foot | 1 | 2024 | 382 | 0.170 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2022 | 344 | 0.170 |
Why?
|
| Polymerase Chain Reaction | 7 | 2009 | 6067 | 0.170 |
Why?
|
| Longitudinal Studies | 15 | 2020 | 14766 | 0.170 |
Why?
|
| Educational Status | 6 | 2016 | 2511 | 0.170 |
Why?
|
| Cocaine-Related Disorders | 2 | 2002 | 458 | 0.170 |
Why?
|
| Hyperinsulinism | 1 | 2003 | 402 | 0.170 |
Why?
|
| RNA-Binding Proteins | 4 | 2016 | 1889 | 0.170 |
Why?
|
| Principal Component Analysis | 2 | 2016 | 950 | 0.170 |
Why?
|
| Gene Expression Regulation | 8 | 2016 | 11923 | 0.170 |
Why?
|
| Diabetic Nephropathies | 2 | 2022 | 974 | 0.170 |
Why?
|
| Membrane Glycoproteins | 2 | 2015 | 3702 | 0.170 |
Why?
|
| Interleukin-4 | 1 | 2003 | 1156 | 0.170 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2002 | 393 | 0.170 |
Why?
|
| Group II Phospholipases A2 | 1 | 2019 | 12 | 0.170 |
Why?
|
| Breast Neoplasms | 10 | 2018 | 21178 | 0.170 |
Why?
|
| Immunity | 2 | 2018 | 1002 | 0.170 |
Why?
|
| Gonadal Steroid Hormones | 3 | 2017 | 707 | 0.160 |
Why?
|
| Physicians | 16 | 2006 | 4593 | 0.160 |
Why?
|
| Chromosomes, Human, X | 3 | 2024 | 319 | 0.160 |
Why?
|
| Acute Disease | 9 | 2017 | 7236 | 0.160 |
Why?
|
| Young Adult | 23 | 2020 | 59980 | 0.160 |
Why?
|
| Crohn Disease | 2 | 2009 | 2295 | 0.160 |
Why?
|
| Circadian Rhythm | 5 | 2010 | 2591 | 0.160 |
Why?
|
| Factor VIII | 3 | 2021 | 349 | 0.160 |
Why?
|
| Mice | 14 | 2024 | 81912 | 0.160 |
Why?
|
| Genes, Mitochondrial | 1 | 2018 | 59 | 0.160 |
Why?
|
| Ovary | 2 | 2021 | 965 | 0.160 |
Why?
|
| Blood Chemical Analysis | 3 | 2012 | 434 | 0.160 |
Why?
|
| Disease Progression | 12 | 2019 | 13646 | 0.160 |
Why?
|
| Lipase | 2 | 2011 | 320 | 0.160 |
Why?
|
| Ethanol | 3 | 2005 | 1330 | 0.160 |
Why?
|
| Microarray Analysis | 2 | 2019 | 751 | 0.160 |
Why?
|
| Lung Neoplasms | 5 | 2020 | 13491 | 0.150 |
Why?
|
| Dietary Supplements | 6 | 2022 | 3446 | 0.150 |
Why?
|
| Calcium | 1 | 2012 | 5792 | 0.150 |
Why?
|
| Up-Regulation | 7 | 2018 | 4143 | 0.150 |
Why?
|
| Polycythemia | 1 | 1999 | 124 | 0.150 |
Why?
|
| Intermittent Claudication | 4 | 2008 | 305 | 0.150 |
Why?
|
| Statistics as Topic | 5 | 2011 | 2350 | 0.150 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 857 | 0.150 |
Why?
|
| Diabetic Angiopathies | 4 | 2009 | 806 | 0.150 |
Why?
|
| HIV Infections | 6 | 2024 | 17542 | 0.150 |
Why?
|
| Carboxylic Acids | 1 | 2018 | 91 | 0.150 |
Why?
|
| Head and Neck Neoplasms | 1 | 2012 | 2930 | 0.150 |
Why?
|
| Ultrasonography, Doppler | 2 | 2018 | 463 | 0.150 |
Why?
|
| Social Class | 3 | 2019 | 2007 | 0.150 |
Why?
|
| Overweight | 4 | 2013 | 2448 | 0.150 |
Why?
|
| Budd-Chiari Syndrome | 2 | 1990 | 24 | 0.150 |
Why?
|
| Atrial Natriuretic Factor | 4 | 2013 | 350 | 0.150 |
Why?
|
| Transaminases | 1 | 2018 | 198 | 0.150 |
Why?
|
| Aneurysm | 1 | 2021 | 343 | 0.150 |
Why?
|
| Abortion, Habitual | 1 | 1998 | 63 | 0.150 |
Why?
|
| Hypothyroidism | 2 | 2020 | 667 | 0.150 |
Why?
|
| Leg | 3 | 2010 | 1087 | 0.150 |
Why?
|
| Coronary Artery Bypass | 4 | 2015 | 2189 | 0.150 |
Why?
|
| Carotenoids | 7 | 1996 | 620 | 0.150 |
Why?
|
| Consanguinity | 1 | 2019 | 460 | 0.140 |
Why?
|
| Antibodies, Viral | 2 | 1999 | 3212 | 0.140 |
Why?
|
| Streptokinase | 4 | 1995 | 186 | 0.140 |
Why?
|
| Verbal Learning | 2 | 2022 | 459 | 0.140 |
Why?
|
| Uterine Neoplasms | 2 | 2019 | 1424 | 0.140 |
Why?
|
| Androgens | 2 | 2024 | 1281 | 0.140 |
Why?
|
| Research Design | 8 | 2017 | 6210 | 0.140 |
Why?
|
| Metabolism | 1 | 2018 | 193 | 0.140 |
Why?
|
| Abdomen | 1 | 2003 | 1138 | 0.140 |
Why?
|
| Colorectal Neoplasms | 5 | 2016 | 6966 | 0.140 |
Why?
|
| Heart Neoplasms | 2 | 1991 | 374 | 0.140 |
Why?
|
| Ribonucleoproteins | 2 | 2017 | 358 | 0.140 |
Why?
|
| N-Acetylgalactosaminyltransferases | 2 | 2014 | 63 | 0.140 |
Why?
|
| Son of Sevenless Proteins | 1 | 2016 | 27 | 0.140 |
Why?
|
| Factor V Deficiency | 1 | 1996 | 10 | 0.140 |
Why?
|
| Guidelines as Topic | 3 | 2016 | 1396 | 0.140 |
Why?
|
| Thyroid Hormones | 1 | 2020 | 408 | 0.140 |
Why?
|
| Menopause, Premature | 2 | 2021 | 124 | 0.140 |
Why?
|
| Evaluation Studies as Topic | 4 | 2001 | 1623 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2017 | 1655 | 0.140 |
Why?
|
| Metabolic Diseases | 1 | 2003 | 684 | 0.140 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2018 | 130 | 0.140 |
Why?
|
| Pyrazoles | 2 | 2021 | 2028 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 3511 | 0.140 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 27 | 0.140 |
Why?
|
| Medical History Taking | 2 | 2018 | 779 | 0.140 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2018 | 347 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 4 | 2019 | 1081 | 0.130 |
Why?
|
| Bacterial Infections | 2 | 2002 | 1390 | 0.130 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2018 | 172 | 0.130 |
Why?
|
| Thrombocytopenia | 2 | 2017 | 1172 | 0.130 |
Why?
|
| Down-Regulation | 3 | 2019 | 2931 | 0.130 |
Why?
|
| Blood Coagulation Factors | 2 | 2003 | 371 | 0.130 |
Why?
|
| Endothelium | 1 | 2019 | 768 | 0.130 |
Why?
|
| Early Termination of Clinical Trials | 2 | 2021 | 70 | 0.130 |
Why?
|
| Carotid Artery Diseases | 2 | 2003 | 872 | 0.130 |
Why?
|
| Birth Order | 1 | 2016 | 93 | 0.130 |
Why?
|
| Morbidity | 4 | 2017 | 1754 | 0.130 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.130 |
Why?
|
| Acetylgalactosamine | 1 | 2016 | 41 | 0.130 |
Why?
|
| Iceland | 2 | 2006 | 183 | 0.130 |
Why?
|
| Chi-Square Distribution | 8 | 2017 | 3431 | 0.130 |
Why?
|
| Pyridones | 1 | 2021 | 819 | 0.130 |
Why?
|
| Drug Tolerance | 1 | 2017 | 365 | 0.130 |
Why?
|
| Gallstones | 2 | 2016 | 285 | 0.130 |
Why?
|
| Physical Conditioning, Animal | 1 | 2019 | 363 | 0.130 |
Why?
|
| Cardiovascular System | 2 | 2022 | 839 | 0.130 |
Why?
|
| DNA-Binding Proteins | 5 | 2023 | 9612 | 0.130 |
Why?
|
| RNA, Viral | 1 | 2024 | 2867 | 0.130 |
Why?
|
| Ligands | 1 | 2023 | 3273 | 0.130 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 1004 | 0.130 |
Why?
|
| Mutation, Missense | 3 | 2017 | 2592 | 0.130 |
Why?
|
| Hematopoiesis | 3 | 2019 | 2056 | 0.120 |
Why?
|
| Coitus | 1 | 2016 | 132 | 0.120 |
Why?
|
| Chlamydia Infections | 1 | 1999 | 365 | 0.120 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1997 | 781 | 0.120 |
Why?
|
| Proteome | 2 | 2023 | 1890 | 0.120 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2024 | 1741 | 0.120 |
Why?
|
| Receptors, Neurokinin-3 | 1 | 2015 | 59 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2016 | 3797 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 2815 | 0.120 |
Why?
|
| Genetic Testing | 6 | 2018 | 3591 | 0.120 |
Why?
|
| Dental Caries | 1 | 2019 | 429 | 0.120 |
Why?
|
| Genetic Linkage | 2 | 2012 | 2342 | 0.120 |
Why?
|
| Carboxy-Lyases | 1 | 2015 | 85 | 0.120 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2008 | 706 | 0.120 |
Why?
|
| Sex Hormone-Binding Globulin | 3 | 2006 | 553 | 0.120 |
Why?
|
| Coffea | 1 | 2014 | 22 | 0.120 |
Why?
|
| Fatty Acid Desaturases | 1 | 2015 | 102 | 0.120 |
Why?
|
| Periodontal Index | 1 | 2015 | 150 | 0.120 |
Why?
|
| Fluoroquinolones | 3 | 2006 | 307 | 0.120 |
Why?
|
| Resource Allocation | 1 | 2017 | 354 | 0.120 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 457 | 0.120 |
Why?
|
| Peptidyl-Dipeptidase A | 3 | 2008 | 325 | 0.120 |
Why?
|
| Drug Discovery | 1 | 2022 | 1068 | 0.120 |
Why?
|
| Seafood | 1 | 2017 | 395 | 0.120 |
Why?
|
| DNA Repair | 2 | 2015 | 2050 | 0.120 |
Why?
|
| Africa | 4 | 2022 | 725 | 0.110 |
Why?
|
| Endophenotypes | 1 | 2016 | 258 | 0.110 |
Why?
|
| Chronic Disease | 4 | 2024 | 9362 | 0.110 |
Why?
|
| DNA Mutational Analysis | 5 | 2017 | 4114 | 0.110 |
Why?
|
| Serum Amyloid P-Component | 1 | 2014 | 46 | 0.110 |
Why?
|
| Diastole | 4 | 2018 | 784 | 0.110 |
Why?
|
| Placebo Effect | 1 | 2018 | 516 | 0.110 |
Why?
|
| Risk-Taking | 1 | 2019 | 1023 | 0.110 |
Why?
|
| Amidinotransferases | 1 | 2013 | 11 | 0.110 |
Why?
|
| Laminin | 1 | 2015 | 404 | 0.110 |
Why?
|
| Computational Biology | 5 | 2018 | 3567 | 0.110 |
Why?
|
| Bone Density | 3 | 2023 | 3573 | 0.110 |
Why?
|
| Leukotriene Antagonists | 1 | 2014 | 124 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 3 | 2012 | 2495 | 0.110 |
Why?
|
| Bibliometrics | 2 | 2008 | 356 | 0.110 |
Why?
|
| Trans Fatty Acids | 1 | 2014 | 155 | 0.110 |
Why?
|
| Erythrocytes | 2 | 2016 | 2411 | 0.110 |
Why?
|
| Antibodies, Bacterial | 1 | 1999 | 1477 | 0.110 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2009 | 2257 | 0.110 |
Why?
|
| Intracranial Hemorrhages | 1 | 2019 | 810 | 0.110 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 872 | 0.110 |
Why?
|
| Parity | 1 | 2016 | 931 | 0.110 |
Why?
|
| Hematologic Diseases | 1 | 2017 | 498 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 4 | 2016 | 5796 | 0.110 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2014 | 260 | 0.110 |
Why?
|
| Acyltransferases | 1 | 2015 | 305 | 0.110 |
Why?
|
| Fishes | 1 | 2016 | 607 | 0.110 |
Why?
|
| Erythrocyte Indices | 1 | 2014 | 143 | 0.110 |
Why?
|
| Asymptomatic Diseases | 2 | 2013 | 588 | 0.110 |
Why?
|
| Behavior | 1 | 2016 | 538 | 0.110 |
Why?
|
| Leukocyte Count | 4 | 2007 | 1606 | 0.100 |
Why?
|
| Syndrome | 7 | 2017 | 3271 | 0.100 |
Why?
|
| Immunity, Humoral | 1 | 2017 | 610 | 0.100 |
Why?
|
| Thromboxane B2 | 3 | 2014 | 143 | 0.100 |
Why?
|
| Secretory Component | 1 | 1992 | 16 | 0.100 |
Why?
|
| Learning | 1 | 2022 | 1754 | 0.100 |
Why?
|
| Blood Cell Count | 1 | 2014 | 404 | 0.100 |
Why?
|
| Erythropoiesis | 1 | 2016 | 691 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 5 | 2019 | 4401 | 0.100 |
Why?
|
| Body Weights and Measures | 1 | 2013 | 208 | 0.100 |
Why?
|
| Glycine | 2 | 2007 | 670 | 0.100 |
Why?
|
| Fibric Acids | 1 | 2012 | 27 | 0.100 |
Why?
|
| Disease | 1 | 2018 | 675 | 0.100 |
Why?
|
| Plasminogen Inactivators | 1 | 1992 | 37 | 0.100 |
Why?
|
| Age of Onset | 3 | 2021 | 3344 | 0.100 |
Why?
|
| Serpins | 1 | 2014 | 246 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2011 | 313 | 0.100 |
Why?
|
| Arginine | 2 | 2007 | 931 | 0.100 |
Why?
|
| rho-Associated Kinases | 1 | 2014 | 290 | 0.100 |
Why?
|
| Membrane Transport Proteins | 2 | 2015 | 1029 | 0.100 |
Why?
|
| Databases, Genetic | 5 | 2018 | 1758 | 0.100 |
Why?
|
| Lipoxins | 2 | 2005 | 419 | 0.100 |
Why?
|
| Lower Extremity | 4 | 2011 | 1217 | 0.100 |
Why?
|
| Geography | 2 | 2011 | 651 | 0.100 |
Why?
|
| Calibration | 2 | 2019 | 817 | 0.100 |
Why?
|
| Likelihood Functions | 2 | 2008 | 996 | 0.100 |
Why?
|
| Alcohol Dehydrogenase | 2 | 2004 | 113 | 0.100 |
Why?
|
| Immunoglobulins | 1 | 2015 | 853 | 0.100 |
Why?
|
| Geographic Atrophy | 1 | 2013 | 92 | 0.100 |
Why?
|
| Homeodomain Proteins | 3 | 2019 | 2429 | 0.100 |
Why?
|
| Receptors, Nicotinic | 1 | 2015 | 494 | 0.100 |
Why?
|
| Prediabetic State | 1 | 2018 | 547 | 0.100 |
Why?
|
| Carcinoid Heart Disease | 1 | 1991 | 11 | 0.100 |
Why?
|
| Sepsis | 2 | 2017 | 2605 | 0.100 |
Why?
|
| Tobacco Use Disorder | 2 | 2015 | 708 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2015 | 594 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 18330 | 0.100 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 605 | 0.100 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2012 | 78 | 0.100 |
Why?
|
| Analysis of Variance | 7 | 2014 | 6215 | 0.100 |
Why?
|
| Apolipoprotein C-III | 2 | 2022 | 209 | 0.100 |
Why?
|
| Cooking | 1 | 2014 | 327 | 0.100 |
Why?
|
| Tricuspid Valve Stenosis | 1 | 1991 | 26 | 0.100 |
Why?
|
| Administration, Oral | 5 | 2009 | 4026 | 0.100 |
Why?
|
| Energy Metabolism | 3 | 2017 | 2906 | 0.090 |
Why?
|
| Health Status | 2 | 2019 | 4091 | 0.090 |
Why?
|
| Food Analysis | 1 | 2012 | 103 | 0.090 |
Why?
|
| Reference Standards | 2 | 2013 | 1011 | 0.090 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 3828 | 0.090 |
Why?
|
| Cognition | 3 | 2019 | 7059 | 0.090 |
Why?
|
| Sirtuins | 1 | 2014 | 322 | 0.090 |
Why?
|
| Amygdala | 1 | 2019 | 1375 | 0.090 |
Why?
|
| Diagnostic Imaging | 2 | 2017 | 3530 | 0.090 |
Why?
|
| Molecular Chaperones | 1 | 2016 | 760 | 0.090 |
Why?
|
| Blood Platelets | 2 | 2006 | 2464 | 0.090 |
Why?
|
| False Positive Reactions | 2 | 2010 | 959 | 0.090 |
Why?
|
| Peroxidase | 2 | 2006 | 610 | 0.090 |
Why?
|
| Biphenyl Compounds | 1 | 2016 | 1026 | 0.090 |
Why?
|
| Autoantigens | 1 | 2015 | 890 | 0.090 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 2011 | 41 | 0.090 |
Why?
|
| Ischemia | 3 | 2024 | 1905 | 0.090 |
Why?
|
| Benzimidazoles | 1 | 2016 | 862 | 0.090 |
Why?
|
| Primary Ovarian Insufficiency | 3 | 2021 | 108 | 0.090 |
Why?
|
| Heparin | 3 | 1998 | 1636 | 0.090 |
Why?
|
| Phospholipids | 1 | 2014 | 778 | 0.090 |
Why?
|
| Epidemiologic Methods | 4 | 2008 | 1326 | 0.090 |
Why?
|
| Body Constitution | 2 | 2001 | 273 | 0.090 |
Why?
|
| Carbon-Carbon Ligases | 1 | 2010 | 19 | 0.090 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 418 | 0.090 |
Why?
|
| Kidney Function Tests | 3 | 2020 | 683 | 0.090 |
Why?
|
| Ventricular Function, Left | 3 | 2020 | 3934 | 0.090 |
Why?
|
| Wet Macular Degeneration | 1 | 2013 | 165 | 0.090 |
Why?
|
| Myocarditis | 1 | 1998 | 802 | 0.090 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2024 | 2586 | 0.090 |
Why?
|
| Treatment Failure | 1 | 2017 | 2658 | 0.090 |
Why?
|
| Health Personnel | 1 | 2024 | 3387 | 0.090 |
Why?
|
| Dietary Sucrose | 1 | 2012 | 242 | 0.090 |
Why?
|
| Lipoproteins, IDL | 1 | 2010 | 18 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2015 | 1002 | 0.090 |
Why?
|
| Angiotensin II | 1 | 1993 | 842 | 0.090 |
Why?
|
| Liver | 7 | 2024 | 7578 | 0.090 |
Why?
|
| Liver Abscess | 1 | 1990 | 81 | 0.090 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 1991 | 187 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2016 | 4522 | 0.090 |
Why?
|
| Death | 1 | 2014 | 685 | 0.090 |
Why?
|
| American Heart Association | 1 | 2015 | 1049 | 0.090 |
Why?
|
| Transcription Factor RelA | 1 | 2011 | 252 | 0.080 |
Why?
|
| Infectious Mononucleosis | 1 | 1990 | 133 | 0.080 |
Why?
|
| Cadherins | 1 | 2014 | 903 | 0.080 |
Why?
|
| Pericardium | 1 | 1994 | 681 | 0.080 |
Why?
|
| Triiodothyronine | 2 | 2024 | 493 | 0.080 |
Why?
|
| I-kappa B Kinase | 1 | 2011 | 250 | 0.080 |
Why?
|
| Plant Poisoning | 1 | 1989 | 13 | 0.080 |
Why?
|
| Apoprotein(a) | 2 | 2006 | 17 | 0.080 |
Why?
|
| Anticarcinogenic Agents | 1 | 2011 | 251 | 0.080 |
Why?
|
| Carcinoid Tumor | 1 | 1991 | 225 | 0.080 |
Why?
|
| Plants, Edible | 1 | 1989 | 29 | 0.080 |
Why?
|
| United Arab Emirates | 1 | 2009 | 42 | 0.080 |
Why?
|
| Insulin, Long-Acting | 1 | 2009 | 59 | 0.080 |
Why?
|
| Exercise Tolerance | 2 | 2023 | 846 | 0.080 |
Why?
|
| Mucoproteins | 1 | 2009 | 49 | 0.080 |
Why?
|
| Genes | 1 | 2013 | 1824 | 0.080 |
Why?
|
| Receptors, Interleukin-4 | 2 | 2006 | 65 | 0.080 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2011 | 319 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 20741 | 0.080 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2011 | 280 | 0.080 |
Why?
|
| Massachusetts | 6 | 2017 | 8890 | 0.080 |
Why?
|
| HIV-1 | 2 | 2024 | 6951 | 0.080 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 733 | 0.080 |
Why?
|
| Qb-SNARE Proteins | 1 | 2008 | 34 | 0.080 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2016 | 742 | 0.080 |
Why?
|
| Pyridines | 1 | 2001 | 2890 | 0.080 |
Why?
|
| Klebsiella Infections | 1 | 1990 | 146 | 0.080 |
Why?
|
| Communicable Diseases | 1 | 2017 | 872 | 0.080 |
Why?
|
| BRCA1 Protein | 1 | 2015 | 1155 | 0.080 |
Why?
|
| Renal Insufficiency | 1 | 2014 | 812 | 0.080 |
Why?
|
| Dietary Fiber | 1 | 2013 | 767 | 0.080 |
Why?
|
| Lymphotoxin-alpha | 1 | 2009 | 94 | 0.080 |
Why?
|
| Mouthwashes | 1 | 1989 | 57 | 0.080 |
Why?
|
| Clinical Protocols | 2 | 2015 | 1443 | 0.080 |
Why?
|
| Students | 1 | 2019 | 1744 | 0.080 |
Why?
|
| Glucose Tolerance Test | 2 | 2012 | 1181 | 0.080 |
Why?
|
| Blood Specimen Collection | 2 | 2007 | 238 | 0.080 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2002 | 766 | 0.080 |
Why?
|
| Antigens, CD | 2 | 2017 | 4032 | 0.080 |
Why?
|
| Glucose | 5 | 2018 | 4341 | 0.080 |
Why?
|
| Thyroid Function Tests | 2 | 2020 | 289 | 0.080 |
Why?
|
| Introns | 3 | 2015 | 965 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2012 | 566 | 0.080 |
Why?
|
| Probability | 4 | 2009 | 2476 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1626 | 0.080 |
Why?
|
| TRPM Cation Channels | 1 | 2009 | 140 | 0.080 |
Why?
|
| Hypertension, Renal | 1 | 2008 | 135 | 0.080 |
Why?
|
| Medicine | 1 | 2016 | 944 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2014 | 1505 | 0.070 |
Why?
|
| Puberty, Delayed | 2 | 2024 | 124 | 0.070 |
Why?
|
| Epidemiologic Research Design | 2 | 2010 | 368 | 0.070 |
Why?
|
| Vitamin D Deficiency | 1 | 2018 | 1389 | 0.070 |
Why?
|
| OX40 Ligand | 1 | 2008 | 57 | 0.070 |
Why?
|
| Chemokine CCL11 | 2 | 2005 | 128 | 0.070 |
Why?
|
| Patient Compliance | 5 | 2024 | 2697 | 0.070 |
Why?
|
| Zebrafish | 3 | 2016 | 3036 | 0.070 |
Why?
|
| Thyrotropin | 2 | 2024 | 834 | 0.070 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 373 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2016 | 14476 | 0.070 |
Why?
|
| Homeostasis | 1 | 2019 | 3345 | 0.070 |
Why?
|
| Activities of Daily Living | 2 | 2008 | 2429 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2017 | 2843 | 0.070 |
Why?
|
| Magnesium | 2 | 2005 | 815 | 0.070 |
Why?
|
| Puberty, Precocious | 2 | 2024 | 166 | 0.070 |
Why?
|
| Sample Size | 2 | 2022 | 845 | 0.070 |
Why?
|
| Memory Disorders | 1 | 2014 | 1193 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 2057 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 6360 | 0.070 |
Why?
|
| GPI-Linked Proteins | 1 | 2009 | 472 | 0.070 |
Why?
|
| Tea | 1 | 1989 | 289 | 0.070 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2014 | 1126 | 0.070 |
Why?
|
| Protective Agents | 1 | 2008 | 150 | 0.070 |
Why?
|
| Gene Regulatory Networks | 4 | 2018 | 1752 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2009 | 341 | 0.070 |
Why?
|
| Rhode Island | 1 | 2008 | 352 | 0.070 |
Why?
|
| Antiporters | 2 | 2019 | 275 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2008 | 174 | 0.070 |
Why?
|
| Hospitalization | 7 | 2023 | 10815 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 3408 | 0.070 |
Why?
|
| Cystatin C | 3 | 2010 | 272 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 1994 | 1424 | 0.070 |
Why?
|
| Ischemic Attack, Transient | 1 | 2012 | 874 | 0.070 |
Why?
|
| Receptors, Androgen | 2 | 2017 | 1089 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 3 | 2018 | 3611 | 0.070 |
Why?
|
| Lung Diseases | 1 | 2017 | 1942 | 0.070 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2007 | 117 | 0.070 |
Why?
|
| Government Regulation | 1 | 2011 | 525 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2021 | 10455 | 0.070 |
Why?
|
| Glycosylation | 2 | 2024 | 1099 | 0.070 |
Why?
|
| Protein C | 2 | 1997 | 134 | 0.070 |
Why?
|
| Ramipril | 2 | 1997 | 102 | 0.070 |
Why?
|
| Activated Protein C Resistance | 2 | 2007 | 18 | 0.070 |
Why?
|
| Bioprosthesis | 1 | 1991 | 593 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 3427 | 0.070 |
Why?
|
| Absorptiometry, Photon | 1 | 2013 | 1757 | 0.070 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2006 | 20 | 0.070 |
Why?
|
| Income | 3 | 2016 | 1877 | 0.070 |
Why?
|
| 5-Lipoxygenase-Activating Proteins | 1 | 2006 | 24 | 0.070 |
Why?
|
| Ascorbic Acid | 2 | 2003 | 658 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 3928 | 0.070 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2006 | 56 | 0.070 |
Why?
|
| Estrogen Receptor beta | 1 | 2007 | 171 | 0.070 |
Why?
|
| Isoprostanes | 1 | 2006 | 21 | 0.070 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2006 | 42 | 0.070 |
Why?
|
| Serine Endopeptidases | 1 | 2011 | 1027 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 3667 | 0.070 |
Why?
|
| Executive Function | 1 | 2015 | 1396 | 0.070 |
Why?
|
| Walking | 3 | 2018 | 1201 | 0.070 |
Why?
|
| Sexual Behavior | 1 | 2016 | 2196 | 0.060 |
Why?
|
| Leisure Activities | 2 | 2022 | 310 | 0.060 |
Why?
|
| Embolism | 1 | 1989 | 401 | 0.060 |
Why?
|
| Residence Characteristics | 1 | 2016 | 2116 | 0.060 |
Why?
|
| Caspase 9 | 2 | 2019 | 184 | 0.060 |
Why?
|
| Prejudice | 1 | 2010 | 569 | 0.060 |
Why?
|
| INDEL Mutation | 2 | 2018 | 266 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2019 | 12158 | 0.060 |
Why?
|
| Child | 17 | 2024 | 80771 | 0.060 |
Why?
|
| Calgranulin B | 1 | 2006 | 87 | 0.060 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2018 | 229 | 0.060 |
Why?
|
| Attention | 1 | 2016 | 2413 | 0.060 |
Why?
|
| Ion Channels | 1 | 2010 | 1043 | 0.060 |
Why?
|
| Hemangioma | 1 | 1991 | 727 | 0.060 |
Why?
|
| Blood Viscosity | 2 | 1999 | 125 | 0.060 |
Why?
|
| Netherlands | 3 | 2019 | 2277 | 0.060 |
Why?
|
| Granulocytes | 1 | 2007 | 551 | 0.060 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2007 | 461 | 0.060 |
Why?
|
| Glycemic Index | 1 | 2008 | 400 | 0.060 |
Why?
|
| Pancreatitis | 1 | 2012 | 1087 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 1996 | 2144 | 0.060 |
Why?
|
| Mitochondria | 1 | 2018 | 3678 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 4 | 2009 | 5537 | 0.060 |
Why?
|
| Drug Prescriptions | 1 | 2014 | 1664 | 0.060 |
Why?
|
| Matrix Metalloproteinases | 1 | 2007 | 391 | 0.060 |
Why?
|
| Methionine | 1 | 2007 | 570 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 3 | 2016 | 1604 | 0.060 |
Why?
|
| Health Status Disparities | 1 | 2017 | 1882 | 0.060 |
Why?
|
| Hyperlipidemia, Familial Combined | 1 | 2004 | 14 | 0.060 |
Why?
|
| Women, Working | 1 | 2005 | 86 | 0.060 |
Why?
|
| Protein Precursors | 2 | 2000 | 1134 | 0.060 |
Why?
|
| Osteoporosis | 2 | 2012 | 1604 | 0.060 |
Why?
|
| Complement Activation | 1 | 2007 | 447 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2020 | 2902 | 0.060 |
Why?
|
| Diuretics | 1 | 2008 | 614 | 0.060 |
Why?
|
| Plasma | 1 | 2008 | 583 | 0.060 |
Why?
|
| Multigene Family | 1 | 2008 | 1081 | 0.060 |
Why?
|
| Mitochondrial Proteins | 1 | 2010 | 980 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2020 | 4745 | 0.060 |
Why?
|
| Investments | 1 | 2006 | 148 | 0.060 |
Why?
|
| Popliteal Artery | 1 | 2006 | 313 | 0.060 |
Why?
|
| Protein Isoforms | 2 | 2006 | 1716 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2007 | 633 | 0.060 |
Why?
|
| Germany | 2 | 2009 | 882 | 0.060 |
Why?
|
| Sulfotransferases | 2 | 2015 | 150 | 0.060 |
Why?
|
| Sulfasalazine | 1 | 2024 | 85 | 0.060 |
Why?
|
| Life Tables | 1 | 2004 | 367 | 0.060 |
Why?
|
| Peptide Hydrolases | 1 | 2007 | 610 | 0.060 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2009 | 606 | 0.060 |
Why?
|
| Apolipoproteins C | 1 | 2003 | 59 | 0.060 |
Why?
|
| Muscle Proteins | 2 | 2020 | 1160 | 0.060 |
Why?
|
| Genomic Imprinting | 2 | 2017 | 326 | 0.060 |
Why?
|
| Arachidonic Acid | 2 | 2014 | 430 | 0.060 |
Why?
|
| Food, Fortified | 1 | 1985 | 189 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2017 | 3266 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2019 | 4526 | 0.050 |
Why?
|
| Genes, Recessive | 1 | 2006 | 624 | 0.050 |
Why?
|
| Somatomedins | 2 | 2017 | 179 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2021 | 11657 | 0.050 |
Why?
|
| Blood Coagulation | 1 | 2009 | 1163 | 0.050 |
Why?
|
| Autoanalysis | 1 | 2003 | 70 | 0.050 |
Why?
|
| Microfilament Proteins | 2 | 2020 | 1130 | 0.050 |
Why?
|
| Body Composition | 1 | 2013 | 2454 | 0.050 |
Why?
|
| Genes, X-Linked | 2 | 2015 | 129 | 0.050 |
Why?
|
| Confidentiality | 1 | 2007 | 607 | 0.050 |
Why?
|
| Troponin | 1 | 2007 | 536 | 0.050 |
Why?
|
| Inheritance Patterns | 2 | 2019 | 344 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2009 | 1182 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2009 | 1493 | 0.050 |
Why?
|
| Nitrites | 1 | 2023 | 156 | 0.050 |
Why?
|
| Biomedical Research | 2 | 2017 | 3464 | 0.050 |
Why?
|
| Models, Biological | 4 | 2015 | 9464 | 0.050 |
Why?
|
| Codon | 2 | 2003 | 599 | 0.050 |
Why?
|
| Lysine | 1 | 2007 | 998 | 0.050 |
Why?
|
| Heart Valve Prosthesis | 1 | 1991 | 1464 | 0.050 |
Why?
|
| Muscle Strength | 1 | 2007 | 640 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2003 | 1515 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2011 | 1672 | 0.050 |
Why?
|
| Communication | 1 | 2017 | 3904 | 0.050 |
Why?
|
| Sex Distribution | 2 | 2009 | 2276 | 0.050 |
Why?
|
| Awareness | 1 | 2007 | 653 | 0.050 |
Why?
|
| Genome | 1 | 2011 | 1752 | 0.050 |
Why?
|
| Proteoglycans | 2 | 2017 | 807 | 0.050 |
Why?
|
| Pedigree | 3 | 2018 | 4539 | 0.050 |
Why?
|
| Biometry | 1 | 2006 | 571 | 0.050 |
Why?
|
| Estrogen Receptor alpha | 2 | 2017 | 581 | 0.050 |
Why?
|
| Time | 1 | 2004 | 551 | 0.050 |
Why?
|
| Response Elements | 1 | 2024 | 308 | 0.050 |
Why?
|
| Gene Expression Profiling | 4 | 2021 | 9532 | 0.050 |
Why?
|
| Veins | 1 | 2006 | 769 | 0.050 |
Why?
|
| Femoral Artery | 1 | 2006 | 827 | 0.050 |
Why?
|
| Cholesterol, VLDL | 2 | 2017 | 70 | 0.050 |
Why?
|
| Thromboplastin | 1 | 2004 | 289 | 0.050 |
Why?
|
| Aspartic Acid | 1 | 2004 | 575 | 0.050 |
Why?
|
| Feeding Behavior | 1 | 2014 | 3207 | 0.050 |
Why?
|
| Adipogenesis | 2 | 2015 | 370 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2008 | 3449 | 0.050 |
Why?
|
| Chemotactic Factors | 1 | 2022 | 197 | 0.050 |
Why?
|
| England | 2 | 2017 | 533 | 0.050 |
Why?
|
| Vaccination | 1 | 2014 | 3434 | 0.050 |
Why?
|
| Fibrinopeptide A | 1 | 2021 | 43 | 0.050 |
Why?
|
| Self Care | 1 | 2007 | 800 | 0.050 |
Why?
|
| Actinin | 1 | 2022 | 165 | 0.050 |
Why?
|
| Data Collection | 2 | 2008 | 3321 | 0.050 |
Why?
|
| Consensus | 4 | 2019 | 3207 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2016 | 4426 | 0.050 |
Why?
|
| Gemfibrozil | 1 | 2001 | 30 | 0.050 |
Why?
|
| Postural Balance | 1 | 2006 | 638 | 0.050 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 582 | 0.050 |
Why?
|
| GATA5 Transcription Factor | 1 | 2020 | 18 | 0.050 |
Why?
|
| Endothelial Cells | 2 | 2022 | 3582 | 0.050 |
Why?
|
| Minisatellite Repeats | 1 | 2001 | 162 | 0.050 |
Why?
|
| Vasodilation | 2 | 2003 | 968 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 588 | 0.050 |
Why?
|
| Coronary Stenosis | 1 | 2007 | 803 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2021 | 183 | 0.050 |
Why?
|
| Phospholipase C beta | 1 | 2020 | 48 | 0.050 |
Why?
|
| Prothrombin Time | 1 | 2021 | 117 | 0.050 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2001 | 131 | 0.050 |
Why?
|
| Factor XI | 1 | 2021 | 40 | 0.050 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2021 | 115 | 0.040 |
Why?
|
| Drosophila | 2 | 2019 | 1509 | 0.040 |
Why?
|
| Population Groups | 1 | 2021 | 209 | 0.040 |
Why?
|
| Adenoma | 1 | 2011 | 2155 | 0.040 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2002 | 199 | 0.040 |
Why?
|
| Mannose-Binding Lectins | 1 | 2001 | 100 | 0.040 |
Why?
|
| Gene Deletion | 2 | 1999 | 2668 | 0.040 |
Why?
|
| Partial Thromboplastin Time | 1 | 2021 | 203 | 0.040 |
Why?
|
| Testosterone | 3 | 2006 | 2490 | 0.040 |
Why?
|
| Survival Analysis | 7 | 2010 | 10092 | 0.040 |
Why?
|
| Parents | 1 | 2014 | 3594 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2016 | 12793 | 0.040 |
Why?
|
| Siblings | 3 | 2012 | 828 | 0.040 |
Why?
|
| Latex | 1 | 1999 | 49 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2019 | 18 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2020 | 3948 | 0.040 |
Why?
|
| Adipocytes | 2 | 2018 | 1197 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2019 | 25 | 0.040 |
Why?
|
| Alzheimer Disease | 2 | 2015 | 8717 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 3599 | 0.040 |
Why?
|
| Receptors, Collagen | 1 | 1999 | 25 | 0.040 |
Why?
|
| Menorrhagia | 1 | 2019 | 59 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 2 | 2022 | 2824 | 0.040 |
Why?
|
| Molecular Sequence Annotation | 1 | 2022 | 526 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2010 | 773 | 0.040 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2019 | 95 | 0.040 |
Why?
|
| Angiotensinogen | 2 | 2011 | 161 | 0.040 |
Why?
|
| Erythrocyte Count | 1 | 1999 | 157 | 0.040 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1999 | 185 | 0.040 |
Why?
|
| Periodontics | 2 | 2009 | 45 | 0.040 |
Why?
|
| Receptors, Vasopressin | 1 | 2019 | 106 | 0.040 |
Why?
|
| Physical Endurance | 1 | 2001 | 369 | 0.040 |
Why?
|
| Heredity | 1 | 2019 | 149 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2020 | 376 | 0.040 |
Why?
|
| Ovarian Neoplasms | 2 | 2013 | 4903 | 0.040 |
Why?
|
| Vasectomy | 1 | 1999 | 52 | 0.040 |
Why?
|
| Antigens | 1 | 2004 | 1442 | 0.040 |
Why?
|
| Nutrition Assessment | 1 | 2002 | 740 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2014 | 2887 | 0.040 |
Why?
|
| Leukocytosis | 1 | 2019 | 248 | 0.040 |
Why?
|
| Plants, Medicinal | 1 | 1999 | 167 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 2023 | 877 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 1992 | 3232 | 0.040 |
Why?
|
| Chest Pain | 1 | 2005 | 1101 | 0.040 |
Why?
|
| Receptors, Leptin | 1 | 2019 | 352 | 0.040 |
Why?
|
| Bone and Bones | 2 | 2021 | 2587 | 0.040 |
Why?
|
| Hematocrit | 1 | 1999 | 622 | 0.040 |
Why?
|
| Demography | 1 | 2003 | 1641 | 0.040 |
Why?
|
| Exercise Test | 4 | 2008 | 2188 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 3 | 2015 | 4780 | 0.040 |
Why?
|
| Stents | 1 | 2010 | 3193 | 0.040 |
Why?
|
| Hepatic Encephalopathy | 1 | 1999 | 143 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 1994 | 4713 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 1999 | 404 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2019 | 828 | 0.040 |
Why?
|
| Goals | 1 | 2003 | 717 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2024 | 2201 | 0.040 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2017 | 141 | 0.040 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 14 | 0.040 |
Why?
|
| Beer | 1 | 1997 | 135 | 0.040 |
Why?
|
| Isoenzymes | 3 | 2004 | 1688 | 0.040 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2017 | 19 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2012 | 832 | 0.040 |
Why?
|
| Uterus | 1 | 2021 | 661 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2022 | 1392 | 0.040 |
Why?
|
| DNA Primers | 1 | 2001 | 2827 | 0.040 |
Why?
|
| Iodide Peroxidase | 1 | 2019 | 295 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2006 | 2428 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2014 | 15824 | 0.030 |
Why?
|
| Sleep Deprivation | 1 | 2004 | 848 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2018 | 1531 | 0.030 |
Why?
|
| Family Practice | 1 | 2000 | 509 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2001 | 966 | 0.030 |
Why?
|
| Running | 1 | 2001 | 489 | 0.030 |
Why?
|
| Ankle | 3 | 2006 | 353 | 0.030 |
Why?
|
| Hyperthyroidism | 1 | 2019 | 292 | 0.030 |
Why?
|
| Kidney Tubules | 1 | 2018 | 454 | 0.030 |
Why?
|
| Islets of Langerhans | 1 | 2003 | 1350 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2024 | 1244 | 0.030 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2017 | 60 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2017 | 411 | 0.030 |
Why?
|
| DNA Helicases | 2 | 2012 | 854 | 0.030 |
Why?
|
| Thromboxanes | 1 | 1996 | 45 | 0.030 |
Why?
|
| Weight Loss | 2 | 2012 | 2716 | 0.030 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2006 | 1456 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 1999 | 627 | 0.030 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2018 | 271 | 0.030 |
Why?
|
| Visual Acuity | 2 | 2017 | 2714 | 0.030 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2020 | 878 | 0.030 |
Why?
|
| Mass Spectrometry | 2 | 2018 | 2201 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2017 | 1900 | 0.030 |
Why?
|
| Muscle, Smooth | 2 | 2016 | 930 | 0.030 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2017 | 187 | 0.030 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2017 | 262 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2016 | 367 | 0.030 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2016 | 77 | 0.030 |
Why?
|
| Myocardium | 4 | 2015 | 4765 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 1996 | 316 | 0.030 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1997 | 184 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 1996 | 861 | 0.030 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2019 | 488 | 0.030 |
Why?
|
| Stroke Volume | 3 | 2023 | 5618 | 0.030 |
Why?
|
| Interferon Regulatory Factors | 1 | 2017 | 271 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2004 | 2140 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2020 | 871 | 0.030 |
Why?
|
| Herpes Simplex | 1 | 1998 | 470 | 0.030 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2015 | 71 | 0.030 |
Why?
|
| Contraceptives, Oral | 1 | 1997 | 560 | 0.030 |
Why?
|
| Base Sequence | 3 | 2012 | 12414 | 0.030 |
Why?
|
| Viral Load | 1 | 2024 | 3385 | 0.030 |
Why?
|
| Epoprostenol | 1 | 1996 | 246 | 0.030 |
Why?
|
| Epidemiologic Studies | 1 | 1998 | 677 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 1996 | 421 | 0.030 |
Why?
|
| Progesterone | 1 | 1999 | 752 | 0.030 |
Why?
|
| Cough | 1 | 1999 | 598 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 287 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2014 | 68 | 0.030 |
Why?
|
| Amiodarone | 1 | 1996 | 217 | 0.030 |
Why?
|
| Disability Evaluation | 3 | 2008 | 1829 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2002 | 1738 | 0.030 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2015 | 131 | 0.030 |
Why?
|
| Cardiotonic Agents | 2 | 2008 | 540 | 0.030 |
Why?
|
| Education | 1 | 2017 | 531 | 0.030 |
Why?
|
| Brazil | 1 | 2019 | 1250 | 0.030 |
Why?
|
| Exons | 2 | 2014 | 2391 | 0.030 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 2014 | 80 | 0.030 |
Why?
|
| Databases, Factual | 3 | 2017 | 8068 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2022 | 1345 | 0.030 |
Why?
|
| Ion Transport | 1 | 2015 | 322 | 0.030 |
Why?
|
| Receptors, GABA-B | 1 | 2014 | 59 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 1150 | 0.030 |
Why?
|
| Telomerase | 1 | 2019 | 751 | 0.030 |
Why?
|
| Integrins | 1 | 1999 | 840 | 0.030 |
Why?
|
| Nitrates | 1 | 1995 | 259 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 2015 | 381 | 0.030 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2014 | 57 | 0.030 |
Why?
|
| Hematinics | 1 | 2017 | 282 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 287 | 0.030 |
Why?
|
| Glycosaminoglycans | 1 | 2017 | 611 | 0.030 |
Why?
|
| Apolipoprotein A-II | 1 | 1993 | 41 | 0.030 |
Why?
|
| Acetyltransferases | 1 | 2015 | 230 | 0.030 |
Why?
|
| Transcription, Genetic | 3 | 2015 | 7611 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2013 | 25 | 0.030 |
Why?
|
| Estradiol | 3 | 2006 | 1951 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2018 | 18989 | 0.030 |
Why?
|
| Echocardiography | 4 | 1997 | 5042 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 735 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 1074 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 1997 | 763 | 0.030 |
Why?
|
| Maternal Age | 1 | 2016 | 804 | 0.030 |
Why?
|
| Erythrocyte Membrane | 1 | 2015 | 438 | 0.030 |
Why?
|
| Penetrance | 1 | 2015 | 388 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2022 | 1592 | 0.030 |
Why?
|
| Internal Medicine | 1 | 2001 | 1064 | 0.030 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2014 | 225 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2020 | 26396 | 0.030 |
Why?
|
| Gene Expression | 2 | 2018 | 7587 | 0.030 |
Why?
|
| Inhibin-beta Subunits | 1 | 2012 | 27 | 0.030 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2012 | 35 | 0.030 |
Why?
|
| Cataract | 1 | 1999 | 837 | 0.030 |
Why?
|
| Melanesia | 1 | 2012 | 13 | 0.030 |
Why?
|
| Amides | 1 | 2015 | 451 | 0.030 |
Why?
|
| Phosphoproteins | 2 | 2012 | 2448 | 0.030 |
Why?
|
| Cross-Over Studies | 3 | 2004 | 2105 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 1993 | 285 | 0.030 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2012 | 81 | 0.030 |
Why?
|
| Biological Transport | 2 | 2013 | 2084 | 0.030 |
Why?
|
| Epinephrine | 1 | 1996 | 782 | 0.030 |
Why?
|
| Potassium Channels | 1 | 2015 | 534 | 0.030 |
Why?
|
| Estrogens | 1 | 1999 | 1536 | 0.030 |
Why?
|
| Bradycardia | 1 | 1994 | 305 | 0.030 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 1992 | 105 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 4968 | 0.020 |
Why?
|
| Inhibins | 1 | 2012 | 210 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2017 | 771 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 1989 | 4422 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2014 | 564 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1998 | 836 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 11097 | 0.020 |
Why?
|
| Lod Score | 1 | 2012 | 600 | 0.020 |
Why?
|
| Health Priorities | 1 | 2015 | 380 | 0.020 |
Why?
|
| Co-Repressor Proteins | 1 | 2012 | 190 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2006 | 3968 | 0.020 |
Why?
|
| Myosins | 1 | 1993 | 406 | 0.020 |
Why?
|
| Professional Practice | 1 | 2014 | 314 | 0.020 |
Why?
|
| Spectrin | 1 | 2012 | 176 | 0.020 |
Why?
|
| Safety | 1 | 2016 | 1157 | 0.020 |
Why?
|
| Troponin I | 1 | 2016 | 659 | 0.020 |
Why?
|
| Periodicals as Topic | 3 | 2009 | 1465 | 0.020 |
Why?
|
| DNA Primase | 1 | 2012 | 110 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2015 | 723 | 0.020 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2011 | 102 | 0.020 |
Why?
|
| Syncope | 1 | 1994 | 431 | 0.020 |
Why?
|
| Pregnancy | 3 | 2016 | 30238 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2011 | 52 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2016 | 812 | 0.020 |
Why?
|
| Epigenomics | 1 | 2017 | 959 | 0.020 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2012 | 205 | 0.020 |
Why?
|
| Preventive Health Services | 1 | 2016 | 570 | 0.020 |
Why?
|
| Ventricular Fibrillation | 1 | 1993 | 538 | 0.020 |
Why?
|
| Vitamin B 12 | 2 | 2004 | 529 | 0.020 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2012 | 170 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 22361 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2019 | 1902 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2012 | 191 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 606 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2016 | 1190 | 0.020 |
Why?
|
| Chromatin | 1 | 2022 | 2980 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2019 | 2028 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2020 | 5388 | 0.020 |
Why?
|
| Femur Neck | 1 | 2012 | 318 | 0.020 |
Why?
|
| Heart | 1 | 2023 | 4429 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 1830 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 1965 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2014 | 703 | 0.020 |
Why?
|
| Tibial Arteries | 1 | 2010 | 60 | 0.020 |
Why?
|
| DNA Repair Enzymes | 1 | 2012 | 342 | 0.020 |
Why?
|
| Protein Phosphatase 1 | 1 | 2010 | 135 | 0.020 |
Why?
|
| Integrin beta Chains | 1 | 2010 | 115 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2012 | 577 | 0.020 |
Why?
|
| Asia | 1 | 2011 | 629 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2011 | 432 | 0.020 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 1999 | 1250 | 0.020 |
Why?
|
| Symporters | 1 | 2012 | 363 | 0.020 |
Why?
|
| Electrocardiography | 3 | 2010 | 6409 | 0.020 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2011 | 308 | 0.020 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2010 | 161 | 0.020 |
Why?
|
| Ankle Brachial Index | 1 | 2010 | 163 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2010 | 322 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2015 | 1075 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2003 | 6000 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 3610 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 2800 | 0.020 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2014 | 621 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2015 | 1182 | 0.020 |
Why?
|
| Diagnosis, Differential | 3 | 2004 | 12986 | 0.020 |
Why?
|
| Hypogonadism | 1 | 2015 | 805 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2012 | 385 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2009 | 127 | 0.020 |
Why?
|
| Markov Chains | 2 | 2003 | 976 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2011 | 640 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5311 | 0.020 |
Why?
|
| Fibrosis | 1 | 2016 | 2078 | 0.020 |
Why?
|
| Mexican Americans | 2 | 2003 | 165 | 0.020 |
Why?
|
| Geriatric Assessment | 2 | 2008 | 1422 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 17608 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2016 | 1865 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 1512 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2012 | 481 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2015 | 2086 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2015 | 1139 | 0.020 |
Why?
|
| Ultraviolet Therapy | 1 | 2008 | 82 | 0.020 |
Why?
|
| Austria | 1 | 2009 | 207 | 0.020 |
Why?
|
| Metabolomics | 1 | 2018 | 1675 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2012 | 661 | 0.020 |
Why?
|
| Tricuspid Valve | 1 | 1991 | 419 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2024 | 4567 | 0.020 |
Why?
|
| Hypotension | 1 | 1994 | 888 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2012 | 661 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 2 | 2010 | 1995 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2009 | 350 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2009 | 370 | 0.020 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 1993 | 856 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 2 | 2003 | 1002 | 0.020 |
Why?
|
| Vitamin K | 1 | 2010 | 314 | 0.020 |
Why?
|
| Pain | 1 | 2023 | 5101 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2008 | 153 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2009 | 386 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2009 | 315 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 1368 | 0.020 |
Why?
|
| Self Report | 1 | 2019 | 3773 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2019 | 81659 | 0.020 |
Why?
|
| Brain | 3 | 2022 | 27163 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2012 | 863 | 0.020 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2011 | 616 | 0.020 |
Why?
|
| Defibrillators, Implantable | 1 | 1996 | 1499 | 0.020 |
Why?
|
| Health Promotion | 1 | 2019 | 2210 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2013 | 1408 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 2829 | 0.020 |
Why?
|
| Terminology as Topic | 2 | 2004 | 1540 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2007 | 202 | 0.020 |
Why?
|
| Health Behavior | 1 | 2018 | 2650 | 0.020 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1988 | 154 | 0.020 |
Why?
|
| Neopterin | 1 | 2006 | 58 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2006 | 113 | 0.020 |
Why?
|
| Peptic Ulcer | 1 | 2007 | 214 | 0.020 |
Why?
|
| Selenoprotein P | 1 | 2005 | 33 | 0.020 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2010 | 383 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2008 | 588 | 0.020 |
Why?
|
| Peptides | 1 | 2018 | 4348 | 0.020 |
Why?
|
| Vasodilator Agents | 2 | 2003 | 988 | 0.020 |
Why?
|
| Arthritis | 1 | 2011 | 684 | 0.020 |
Why?
|
| Blood Coagulation Disorders | 1 | 1989 | 350 | 0.020 |
Why?
|
| Cerebellum | 1 | 2013 | 1521 | 0.020 |
Why?
|
| Survivors | 1 | 1996 | 2381 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2008 | 784 | 0.020 |
Why?
|
| Radiography | 2 | 1994 | 6975 | 0.020 |
Why?
|
| Synapses | 1 | 2015 | 1759 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2007 | 515 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2018 | 8732 | 0.020 |
Why?
|
| Family | 1 | 2016 | 3210 | 0.020 |
Why?
|
| Toes | 1 | 2006 | 209 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2007 | 939 | 0.020 |
Why?
|
| Thymine | 1 | 2005 | 69 | 0.010 |
Why?
|
| Albumins | 1 | 2007 | 577 | 0.010 |
Why?
|
| Tachycardia, Ventricular | 1 | 1993 | 1313 | 0.010 |
Why?
|
| Emotions | 1 | 2016 | 2760 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1993 | 3552 | 0.010 |
Why?
|
| Albuminuria | 1 | 2008 | 658 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2009 | 1494 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2009 | 1211 | 0.010 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2004 | 28 | 0.010 |
Why?
|
| Central Nervous System Depressants | 1 | 2005 | 163 | 0.010 |
Why?
|
| Hand Strength | 1 | 2007 | 466 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 2006 | 512 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2013 | 2493 | 0.010 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2004 | 62 | 0.010 |
Why?
|
| Heart Arrest | 1 | 1994 | 1516 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 2252 | 0.010 |
Why?
|
| Boston | 1 | 1997 | 9360 | 0.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1993 | 1337 | 0.010 |
Why?
|
| Molecular Epidemiology | 1 | 2006 | 473 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2006 | 897 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 3440 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 319 | 0.010 |
Why?
|
| Cytosine | 1 | 2005 | 213 | 0.010 |
Why?
|
| Alcoholic Beverages | 1 | 2005 | 266 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 2009 | 1250 | 0.010 |
Why?
|
| Guanine | 1 | 2005 | 280 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 2009 | 963 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 1996 | 3618 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2007 | 996 | 0.010 |
Why?
|
| Plasminogen Activators | 1 | 2003 | 199 | 0.010 |
Why?
|
| Acetylation | 1 | 2005 | 1055 | 0.010 |
Why?
|
| Cerebellar Neoplasms | 1 | 1988 | 590 | 0.010 |
Why?
|
| Vitamin B 6 | 1 | 2004 | 237 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 2006 | 591 | 0.010 |
Why?
|
| Hypertension, Portal | 1 | 1985 | 229 | 0.010 |
Why?
|
| China | 1 | 2009 | 2394 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2012 | 1885 | 0.010 |
Why?
|
| Public Health Practice | 1 | 2004 | 220 | 0.010 |
Why?
|
| Heart Ventricles | 2 | 1993 | 3837 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2015 | 7121 | 0.010 |
Why?
|
| Megakaryocytes | 1 | 2006 | 557 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2010 | 2047 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2006 | 1824 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2012 | 2979 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 5130 | 0.010 |
Why?
|
| Physical Fitness | 1 | 2005 | 744 | 0.010 |
Why?
|
| Necrosis | 1 | 1985 | 1614 | 0.010 |
Why?
|
| Nurses | 1 | 2010 | 2501 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 1989 | 1205 | 0.010 |
Why?
|
| Chemokines | 1 | 2004 | 963 | 0.010 |
Why?
|
| Microcirculation | 1 | 2005 | 1282 | 0.010 |
Why?
|
| Locomotion | 1 | 2003 | 388 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2001 | 393 | 0.010 |
Why?
|
| Antifibrinolytic Agents | 1 | 2003 | 289 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2018 | 6977 | 0.010 |
Why?
|
| Rats, Inbred SHR | 1 | 1999 | 187 | 0.010 |
Why?
|
| Cell Line | 1 | 2013 | 15567 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 2011 | 2085 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 2003 | 646 | 0.010 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2004 | 788 | 0.010 |
Why?
|
| Adenine | 1 | 2005 | 995 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4572 | 0.010 |
Why?
|
| Indoles | 1 | 2007 | 1836 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1989 | 1660 | 0.010 |
Why?
|
| Infant | 2 | 2012 | 36485 | 0.010 |
Why?
|
| Decision Making | 1 | 1992 | 3951 | 0.010 |
Why?
|
| Platelet Activation | 1 | 2001 | 643 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2006 | 2114 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 1243 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2010 | 2787 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1999 | 1647 | 0.010 |
Why?
|
| Carcinoma | 1 | 1988 | 2326 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 1794 | 0.010 |
Why?
|
| Anistreplase | 1 | 1995 | 11 | 0.010 |
Why?
|
| Hirudin Therapy | 1 | 1995 | 43 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2009 | 6260 | 0.010 |
Why?
|
| Carotid Stenosis | 1 | 2003 | 858 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2012 | 42606 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 13411 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 36582 | 0.010 |
Why?
|
| Counseling | 1 | 2003 | 1553 | 0.010 |
Why?
|
| Weight Gain | 1 | 2005 | 2360 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 1992 | 5519 | 0.010 |
Why?
|
| Biological Availability | 1 | 1995 | 387 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 13650 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1995 | 612 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1999 | 1836 | 0.010 |
Why?
|
| Intestinal Absorption | 1 | 1995 | 400 | 0.010 |
Why?
|
| Texas | 1 | 1995 | 410 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 1995 | 276 | 0.010 |
Why?
|
| Swine | 1 | 2003 | 5987 | 0.010 |
Why?
|
| Bundle-Branch Block | 1 | 1995 | 280 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 1992 | 7871 | 0.010 |
Why?
|
| Registries | 1 | 2009 | 8351 | 0.010 |
Why?
|
| Heart Rate | 1 | 2004 | 4209 | 0.010 |
Why?
|
| Aorta | 1 | 1999 | 2045 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2007 | 3683 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1999 | 3154 | 0.010 |
Why?
|
| Posture | 1 | 1994 | 956 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1995 | 2221 | 0.000 |
Why?
|
| Environmental Exposure | 1 | 2004 | 4546 | 0.000 |
Why?
|
| Depression | 1 | 2008 | 8234 | 0.000 |
Why?
|
| Adjuvants, Immunologic | 1 | 1993 | 998 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1997 | 4186 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1999 | 11063 | 0.000 |
Why?
|
| Multiple Sclerosis | 1 | 1999 | 3229 | 0.000 |
Why?
|
| Rats | 1 | 1999 | 23713 | 0.000 |
Why?
|
| Medicare | 1 | 1998 | 6813 | 0.000 |
Why?
|